The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Castlight Health Inc

NYSE: CSLT
Last

(U.S.) $4.18

Today's change0.00 0.00%
Updated August 25 4:02 PM EDT. Delayed by at least 15 minutes.
 

Castlight Health Inc

NYSE: CSLT
Last

(U.S.) $4.18

Today's change0.00 0.00%
Updated August 25 4:02 PM EDT. Delayed by at least 15 minutes.

Castlight Health Inc closed at (U.S.)$4.18.

Shares have lost 4.57% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 36.86% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $4.18
  • High--
  • Low--
  • Bid / Ask(U.S.) $2.13 / (U.S.) $0.00
  • YTD % change-2.11%
  • Volume0
  • Average volume (10-day)391,756
  • Average volume (1-month)474,166
  • Average volume (3-month)392,853
  • 52-week range(U.S.) $2.54 to (U.S.) $5.88
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.80
Updated August 25 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-88.48%

Castlight Health Inc has a net profit margin of -88.48%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.03%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue24232120
Total other revenue--------
Total revenue24232120
Gross profit15131211
Total cost of revenue99109
Total operating expense40444040
Selling / general / administrative21252323
Research & development101088
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-17-21-19-20
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-17-21-19-20
Income after tax-17-21-19-20
Income tax, total--------
Net income-17-21-19-20
Total adjustments to net income--------
Net income before extra. items-17-21-19-20
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-17-21-19-20
Inc. avail. to common incl. extra. items-17-21-19-20
Diluted net income-17-21-19-20
Dilution adjustment--------
Diluted weighted average shares100969594
Diluted EPS excluding extraordinary itemsvalue per share-0.17-0.22-0.20-0.21
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.17-0.22-0.20-0.21